Neuropsychiatry

Latest News

The treatment significantly reduced the frequency of cataplexy attacks in patients with narcolepsy compared with placebo.
Phase 3 Trial of AXS-12 for Narcolepsy Meets Primary Endpoint

March 26th 2024

The treatment significantly reduced the frequency of cataplexy attacks in patients with narcolepsy compared with placebo.

neuromodulation
Neuromodulation Approaches to Depressive Disorders

March 21st 2024

diabetes
The Relationship Between Glucose Fluctuations and Cognition in Patients With Type 1 Diabetes

March 18th 2024

From mild cognitive impairment and serotonin system degeneration to an update on pimavanserin for negative symptoms of schizophrenia, here are highlights from the week in Psychiatric Times.
The Week in Review: March 11-15

March 16th 2024

“If we can show that serotonin loss over time is directly involved in the transition from mild cognitive impairment to Alzheimer disease, recently developed antidepressant medications may be an effective way to improve memory deficits and depressive symptoms and, thus, may be a powerful way forward to slow disease progression.”
Mild Cognitive Impairment and Serotonin System Degeneration

March 14th 2024

Video Interviews
Podcasts
©Lenestan/Shutterstock
©Lightspring/Shutterstock
Latest CME Events & Activities

The Expanding Role of Fluid Biomarkers in the Diagnosis and Management of Patients With Alzheimer Disease

View More

Clinical Consultations™: Considerations for Customizing Care Plans for Patients with Parkinson Disease Psychosis

View More

Expert Illustrations & Commentaries™: Visualizing New Therapeutic Targets in Schizophrenia

View More

Advances In™ Schizophrenia: Expanding the Therapeutic Landscape

View More

Southern California Psychiatry Conference

September 13-14, 2024

Register Now!

Updates on New and Emerging Therapies to Improve Outcomes for Patients With Major Depressive Disorder

View More

2023 Annual Psychiatric Times™ World CME Conference

View More

5th Annual International Congress on the Future of Neurology®

View More

Clinical Consultations™: Managing Depressive Episodes in Patients with Bipolar Disorder Type II

View More

Medical Crossfire®: Understanding the Advances in Bipolar Disease Treatment—A Comprehensive Look at Treatment Selection Strategies

View More

Patient, Provider, and Caregiver Connection™: Exploring Unmet Needs In Postpartum Depression – Making the Case for Early Detection and Novel Treatments

View More

'REEL’ Time Patient Counseling: The Diagnostic and Treatment Journey for Patients With Bipolar Disorder Type II – From Primary to Specialty Care

View More

More Than ‘Blue’ After Birth: Managing Diagnosis and Treatment of Post-Partum Depression

View More

More News

© 2024 MJH Life Sciences

All rights reserved.